{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:20:38Z","timestamp":1790709638584,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"KAKENHI","award":["23689024"],"award-info":[{"award-number":["23689024"]}]},{"name":"KAKENHI","award":["26712025"],"award-info":[{"award-number":["26712025"]}]},{"DOI":"10.13039\/501100001695","name":"JST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004532","name":"JICA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009037","name":"SATREPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbrc.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T02:16:48Z","timestamp":1496456208000},"page":"528-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection"],"prefix":"10.1016","volume":"489","author":[{"given":"Satoko","family":"Omachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuho","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizu","family":"Sanjoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8654-7888","authenticated-orcid":false,"given":"Yasuyuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.06.005_bib1","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2017.06.005_bib2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2017.06.005_bib3","doi-asserted-by":"crossref","first-page":"e3374","DOI":"10.1371\/journal.pntd.0003374","article-title":"Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil","volume":"8","author":"Coura-Vital","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbrc.2017.06.005_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.13-0150","article-title":"Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya","volume":"90","author":"Mueller","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2017.06.005_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/342057","article-title":"Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit","volume":"35","author":"Sundar","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2017.06.005_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4269\/ajtmh.14-0260","article-title":"Elevation of serum B-cell activating factor levels during visceral leishmaniasis","volume":"91","author":"Goto","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2017.06.005_bib7","first-page":"318","article-title":"Serological investigations on Indian kala-azar","volume":"40","author":"Ghose","year":"1980","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A\u00a0role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2017.06.005_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.1997.56.522","article-title":"Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis","volume":"56","author":"Sundar","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2017.06.005_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4269\/ajtmh.1998.59.426","article-title":"Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis","volume":"59","author":"Atta","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2017.06.005_bib11","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"Stager","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2017.06.005_bib12","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib13","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/iai.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2017.06.005_bib14","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/iai.63.12.4894-4899.1995","article-title":"Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection","volume":"63","author":"Satoskar","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2017.06.005_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","article-title":"BAFF, APRIL and human B cell disorders","volume":"18","author":"Tangye","year":"2006","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib16","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","article-title":"Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice","volume":"97","author":"Khare","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2017.06.005_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2017.06.005_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2017.06.005_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-472X(01)00774-3","article-title":"BLyS and BLyS receptor expression in non-Hodgkin's lymphoma","volume":"30","author":"Briones","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib21","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2005-09-3552","article-title":"B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia","volume":"107","author":"Elsawa","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.005_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/infdis\/jir438","article-title":"The plasma concentration of the B cell activating factor is increased in children with acute malaria","volume":"204","author":"Nduati","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2017.06.005_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.bbrc.2017.06.005_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","article-title":"Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus","volume":"10","author":"Doreau","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2014.01.141","article-title":"Efficient generation of genome-modified mice via offset-nicking by CRISPR\/Cas system","volume":"445","author":"Fujii","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.06.005_bib26","first-page":"491","article-title":"Cracking the BAFF code, Nature reviews","volume":"9","author":"Mackay","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2017.06.005_bib27","doi-asserted-by":"crossref","first-page":"e0004505","DOI":"10.1371\/journal.pntd.0004505","article-title":"Hemophagocytosis in experimental visceral leishmaniasis by Leishmania donovani","volume":"10","author":"Morimoto","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbrc.2017.06.005_bib28","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2017.06.005_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O'Connor","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2017.06.005_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02915123","article-title":"Splenic haematopoiesis in primary (idiopathic) osteomyelofibrosis: immunohistochemical and morphometric evaluation of proliferative activity of erytro- and endoreduplicative capacity of megakaryopoiesis (PCNA- and Ki-67 staining)","volume":"64","author":"Thiele","year":"1993","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2014.01.003","article-title":"The accumulation of macrophages expressing myeloid-related protein 8 (MRP8) and MRP14 in the spleen of BALB\/cA mice during infection with Plasmodium berghei","volume":"138","author":"Mizobuchi","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2017.06.005_bib33","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.164.7.3681","article-title":"B\u00a0cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology","volume":"164","author":"Smelt","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib34","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.132.4.2072","article-title":"Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway","volume":"132","author":"Sacks","year":"1984","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/intimm\/6.8.1117","article-title":"The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice","volume":"6","author":"Hoerauf","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/intimm\/8.10.1569","article-title":"Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism","volume":"8","author":"Hoerauf","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.005_bib38","doi-asserted-by":"crossref","first-page":"E4094","DOI":"10.1073\/pnas.1421580112","article-title":"TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection","volume":"112","author":"Allman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:13:31Z","timestamp":1757762011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1731104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0006291X1731104X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.005","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}